Qualcomm quickly corrected a widely circulated narrative.

On October 5, Huawei and Qualcomm announced a multi-year patent licensing agreement, enabling cross-licensing of patent portfolios across 5G, computing, AI, and networking. Qualcomm will also acquire some of Huawei's U.S. patents. A dramatic interpretation quickly spread: 25 years after Huawei paid Qualcomm for patent licenses, the roles had reversed.

A day later, Qualcomm clarified to multiple media outlets that while specific terms remained confidential, reports labeling it as a 'net payer' under the agreement were inaccurate. The company confirmed plans to acquire select non-cellular U.S. patents held by Huawei across multiple technology domains.

Discrepancies persist in public statements regarding logic-folding chip technology—a key area tied to Huawei's 'Tao's Law.' Qualcomm denied related claims, while Shenzhen TV reported verification from Huawei that the licensing covers near-package optical interconnect technology and patents supporting logic-folding chips. Neither company's October 5 announcement mentioned logic folding.

Qualcomm's correction deflated 'role reversal' drama, but unresolved technical scope disagreements hint at a more intriguing story.

Over 25 years, Qualcomm and Huawei's once-clear licensing relationship has been rewritten through R&D investment, standard evolution, and business expansion. While competition persists and their chip supplier-customer dynamic lingers, intellectual property ties now defy simple financial descriptions.

They are becoming inseparable partners.

01 From Entry Tickets to Seats at the Table

In 2001, Huawei signed a CDMA patent licensing deal with Qualcomm. According to Qualcomm's announcement, this commercial agreement required royalty payments, granting Huawei rights to Qualcomm's CDMA patent portfolio for developing, producing, and selling cdmaOne and CDMA2000 equipment globally.

Their positions were clear then: Qualcomm dominated mobile communications through CDMA and its IP ecosystem, selling both chips and technology rights. Huawei, in early global expansion, needed patent clearance to enter the CDMA market.

The telecom industry uniquely reshapes underdogs' fates—companies using others' standards today may shape them tomorrow. After decades of technical accumulation, only patent rights protected by law and market share remain at the negotiating table.

Over two decades, Huawei evolved from standard adopter to key contributor.

Polar Code offers a case study. Proposed by Turkish scholar Erdal Arıkan, Huawei drove extensive research, validation, and standardization efforts. In 2016, 3GPP adopted Polar Code for 5G eMBB control channels. Both companies' current announcements highlight Huawei's 4G/5G standard contributions through this technology.

After sustained investment, patent dynamics shifted. By end-2025, Huawei held ~165,000 active global patents (90%+ inventions), including 30,000+ U.S. grants.

When Huawei and Qualcomm returned to negotiations, their bargaining positions had radically evolved. While Qualcomm maintained a vast wireless IP portfolio, Huawei now wielded significant licensable technology rights. The clear licensor-licensee relationship gave way to mutual patent valuation.

02 From Chips to Patents

More telling of the times: this IP convergence occurred after product relationships frayed.

On May 7, 2024, the U.S. Commerce Department revoked Qualcomm's export licenses for 4G and certain other IC products to Huawei. Qualcomm disclosed $560 million in Huawei-related revenue for FY2024 before the revocation, expecting none thereafter—a stance maintained in 2026 regulatory filings.

While chip supplies dried up, patent relationships persisted.

In 2020, the companies signed a new long-term global patent deal after resolving disputes, granting Qualcomm cross-licenses to some Huawei patents. Qualcomm recognized $1.8 billion from this settlement and new licenses, with Huawei as the clear payer.

That agreement expired in 2025. Qualcomm's FY2024 report noted several major OEM deals would end early in the fiscal year, later confirming Huawei's agreement had lapsed—with no royalty revenue recorded from Q2 2025 onward. Negotiations continued until October 2026, culminating in the new multi-year deal.

This highlights modern tech's paradox: export controls sever chip supplies and shrink product ties, but decades-old IP relationships endure.

Technical standards persist, licensed patents remain legally protected, and future products may still utilize existing IP from both companies and the broader ICT ecosystem.

03 From Competition to Entanglement

The 2026 agreement marks another shift by expanding beyond traditional cellular tech.

Announcements reveal cross-licensing covers 5G, computing, AI, and networking, with Qualcomm purchasing some of Huawei's non-cellular U.S. patents. Neither disclosed specific patents, royalty rates, or asset prices, leaving weightings across fields unclear.

But the technical landscape has transformed.

Qualcomm has reduced smartphone dependency, expanding into automotive, PCs, IoT, edge AI, and data centers. Huawei similarly diversified beyond telecom equipment and phones into computing, AI, networking, and automotive. As both companies entered broader computing realms, potential IP overlaps expanded.

This explains why 'who licenses whom' no longer suffices.

Cross-licensing remains standard for tech giants managing complex IP. Negotiating individual licenses or litigation would prove prohibitively expensive. Patent portfolio exchanges resolve years of potential friction at once.

Patent values rarely match perfectly, requiring financial settlements. Qualcomm dismissed 'net payer' reports as inaccurate while keeping core terms confidential. Insufficient evidence exists to determine net royalty flows or interpret its U.S. patent purchases as 'reverse patent taxes.'

The confirmed facts carry weight.

Qualcomm contributed its decades-built IP portfolio while Huawei offered 5G, computing, AI, and networking patents. Both gained usage rights, with some of Huawei's U.S. non-cellular patents transferring to Qualcomm. Simple licensing has evolved into mutual technical valuation.

Huawei stated the deal would bring its total patent licensing value above $6.9 billion—referring to overall contract worth, not cash received from Qualcomm.

Twenty-five years brought no clear victory.

In 2001, Huawei needed Qualcomm's CDMA licenses to sell equipment. By 2026, while Qualcomm maintained leading communications IP, Huawei held assets warranting serious negotiation, cross-licensing, and outright purchases. Product relationships ebbed and flowed, but technical ties deepened as capabilities expanded, defying simple categorization.

Such paradoxes define tech. Product cycles fade and supply chains reconfigure, but technologies embedded in standards, patents, and infrastructure endure far longer.

Chips may stop flowing, but patents demand fresh dialogue.

Qualcomm and Huawei are becoming inseparable partners.